636P Tucatinib and Trastuzumab in Advanced Cancers with HER2 Mutations or Amplification: A Molecular Screening and Therapeutics (most) Program Substudy
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined